As such, the MST1/2 kinases are better recruited into and inactivated by the STRIPAK complex, which relieves the inhibitory effect of MST1/2 on ZMYND8 recruitment to DSBs, thereby allowing for efficient DSB repair and endowing cancer cells with resistance to radio- and chemotherapy (Supplemental Figure 11A). Here, MST1 is linked to cancer.